Marvel Biosciences Corp. (TSXV: MRVL)
Health Care · Biotechnology · CA
CA$0.10
-13.04% today · -53.5% 1Y
Marvel Biosciences Corp. (TSXV: MRVL) operates in the Biotechnology industry within the Health Care sector. The company is valued at $5.22M and employs 5 people.
Over the last twelve months the share price has lost 53.5%, trading between 0.10 and 0.25.
Tweenvest scores Marvel Biosciences Corp. across four factors: quality 16/100, value 59/100. Its strongest factor is value.
MRVL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.22M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- 0.49
- 52-week high
- CA$0.25
- 52-week low
- CA$0.10
- Avg volume (3M)
- —
- Shares outstanding
- 73.80M
- Employees
- 5
- Next earnings
- —
About Marvel Biosciences Corp.
Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company’s lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimer’s disease and autism spectrum disorder, as well as depression and anxiety. It provides non-hallucinogenic neuroplasticity program. The company is headquartered in Calgary, Canada.
- ISIN
- CA57384M1077
- Listed since
- Jul 13, 2021
- Exchange
- TSX Venture Exchange
- Currency
- CAD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| NeuroSense Therapeutics Ltd.NasdaqCM: NRSN | $5.68M | $3.07 | -16.12% |
| Quantum Genomics Société AnonymeENXTPA: ALQGC | $5.65M | €0.07 | -0.28% |
| LianMedicalOTCPK: LIAN.Y | $5.52M | $0.05 | -12.45% |
| Alpha Compute CorpNasdaqCM: ALP | $5.27M | $3.40 | -14.36% |
| AIM ImmunoTech Inc.NYSEAM: AIM | $5.12M | $0.17 | -6.61% |
| Plant Advanced Technologies SAENXTPA: ALPAT | $5.01M | €3.98 | +1.02% |
| Cardio Diagnostics Holdings, Inc.NasdaqCM: CDIO | $5.00M | $1.69 | -9.63% |
| genXone S.A.WSE: GX1 | $4.90M | zł5.76 | -2.37% |
Figures last refreshed Oct 18, 2026.